Cargando…

Mesenchymal stromal cells in renal ischemia/reperfusion injury

Ischemia/reperfusion (I/R) injury is an inevitable consequence of organ transplantation and a major determinant of patient and graft survival in kidney transplantation. Renal I/R injury can lead to fibrosis and graft failure. Although the exact sequence of events in the pathophysiology of I/R injury...

Descripción completa

Detalles Bibliográficos
Autores principales:	de Vries, Dorottya K., Schaapherder, Alexander F. M., Reinders, Marlies E. J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Research Foundation 2012
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3387652/ https://www.ncbi.nlm.nih.gov/pubmed/22783252 http://dx.doi.org/10.3389/fimmu.2012.00162

Ejemplares similares

Mesenchymal Stromal Cell Therapy in Ischemia/Reperfusion Injury
por: Rowart, Pascal, et al.
Publicado: (2015)

Advances in the study of B cells in renal ischemia-reperfusion injury
por: Fan, Hongzhao, et al.
Publicado: (2023)

Comprehensive analysis of necroptosis-related genes in renal ischemia-reperfusion injury
por: Li, Shuai, et al.
Publicado: (2023)

Minimizing Ischemia Reperfusion Injury in Xenotransplantation
por: Patel, Parth M., et al.
Publicado: (2021)

Integrated Analysis of Prognostic Genes Associated With Ischemia–Reperfusion Injury in Renal Transplantation
por: Zhang, Di, et al.
Publicado: (2021)

Group 2 Innate Lymphoid Cells Are Redundant in Experimental Renal Ischemia-Reperfusion Injury
por: Cameron, Guy J. M., et al.
Publicado: (2019)

Dynamics of necroptosis in kidney ischemia-reperfusion injury
por: Pefanis, Aspasia, et al.
Publicado: (2023)

Labile Heme Aggravates Renal Inflammation and Complement Activation After Ischemia Reperfusion Injury
por: Wang, Li, et al.
Publicado: (2019)

Substance P Improves Renal Ischemia Reperfusion Injury Through Modulating Immune Response
por: Kim, Dong-Jin, et al.
Publicado: (2020)

TSC1 Affects the Process of Renal Ischemia-Reperfusion Injury by Controlling Macrophage Polarization
por: Hu, Xiao, et al.
Publicado: (2021)

Hydroxychloroquine Inhibits Macrophage Activation and Attenuates Renal Fibrosis After Ischemia-Reperfusion Injury
por: Zheng, Haofeng, et al.
Publicado: (2021)

Natural Killer Cells in Hepatic Ischemia-Reperfusion Injury
por: Huang, Miao, et al.
Publicado: (2022)

Platelet Contributions to Myocardial Ischemia/Reperfusion Injury
por: Schanze, Nancy, et al.
Publicado: (2019)

Platelets as Modulators of Cerebral Ischemia/Reperfusion Injury
por: Stegner, David, et al.
Publicado: (2019)

NLRP3: Role in ischemia/reperfusion injuries
por: Ghafouri-Fard, Soudeh, et al.
Publicado: (2022)

The role of extracellular traps in ischemia reperfusion injury
por: Zhang, Feilong, et al.
Publicado: (2022)

Mesenchymal Stromal Cell Derived Membrane Particles Are Internalized by Macrophages and Endothelial Cells Through Receptor-Mediated Endocytosis and Phagocytosis
por: da Costa Gonçalves, Fabiany, et al.
Publicado: (2021)

Gene signature and prediction model of the mitophagy-associated immune microenvironment in renal ischemia-reperfusion injury
por: Chen, Ruo-Yang, et al.
Publicado: (2023)

Administration of mesenchymal stromal cells before renal ischemia/reperfusion attenuates kidney injury and may modulate renal lipid metabolism in rats
por: Erpicum, Pauline, et al.
Publicado: (2017)

Role of hepatic stellate cells in liver ischemia-reperfusion injury
por: Peng, Yuming, et al.
Publicado: (2022)

Characterization of early myocardial inflammation in ischemia-reperfusion injury
por: Wu, Qihong, et al.
Publicado: (2023)

Preclinical models versus clinical renal ischemia reperfusion injury: A systematic review based on metabolic signatures
por: Lerink, Lente J. S., et al.
Publicado: (2021)

Mesenchymal Stromal Cell-Based Therapy
por: Mönch, Dina, et al.
Publicado: (2023)

Poly (ADP-Ribose) Polymerase Inhibitor Treatment as a Novel Therapy Attenuating Renal Ischemia-Reperfusion Injury
por: Jang, Hye Ryoun, et al.
Publicado: (2020)

The Pathogenesis of Ischemia-Reperfusion Induced Acute Kidney Injury Depends on Renal Neutrophil Recruitment Whereas Sepsis-Induced AKI Does Not
por: Li, Zhenhan, et al.
Publicado: (2022)

Tissue Dependent Role of PTX3 During Ischemia-Reperfusion Injury
por: de Oliveira, Thiago Henrique Caldeira, et al.
Publicado: (2019)

Complement Initiation Varies by Sex in Intestinal Ischemia Reperfusion Injury
por: Wu, Miaomiao, et al.
Publicado: (2021)

TFNR2 in Ischemia-Reperfusion Injury, Rejection, and Tolerance in Transplantation
por: Kouyoumdjian, Araz, et al.
Publicado: (2022)

The research development of STAT3 in hepatic ischemia-reperfusion injury
por: Yang, Hanwen, et al.
Publicado: (2023)

Comparison of human adipose stromal vascular fraction and adipose-derived mesenchymal stem cells for the attenuation of acute renal ischemia/reperfusion injury
por: Zhou, Liuhua, et al.
Publicado: (2017)

Metabolic Flexibility and Innate Immunity in Renal Ischemia Reperfusion Injury: The Fine Balance Between Adaptive Repair and Tissue Degeneration
por: Tammaro, Alessandra, et al.
Publicado: (2020)

Trib1 Contributes to Recovery From Ischemia/Reperfusion-Induced Acute Kidney Injury by Regulating the Polarization of Renal Macrophages
por: Xie, Xiangcheng, et al.
Publicado: (2020)

Long-Term Protection of CHBP Against Combinational Renal Injury Induced by Both Ischemia–Reperfusion and Cyclosporine A in Mice
por: Zhang, Yufang, et al.
Publicado: (2021)

Cellular Stress Response and Immune Signaling in Retinal Ischemia–Reperfusion Injury
por: Minhas, Gillipsie, et al.
Publicado: (2016)

Liraglutide Attenuates Hepatic Ischemia–Reperfusion Injury by Modulating Macrophage Polarization
por: Li, Shang-Lin, et al.
Publicado: (2022)

Primary Graft Dysfunction: The Role of Aging in Lung Ischemia-Reperfusion Injury
por: Roesel, Maximilian J., et al.
Publicado: (2022)

GPX3 and GSTT1 as biomarkers related to oxidative stress during renal ischemia reperfusion injuries and their relationship with immune infiltration
por: Pei, Jun, et al.
Publicado: (2023)

Type 1 Innate Lymphoid Cells Are Proinflammatory Effector Cells in Ischemia-Reperfusion Injury of Steatotic Livers
por: Kang, Jiman, et al.
Publicado: (2022)

Dendritic Cell-Mediated Regulation of Liver Ischemia-Reperfusion Injury and Liver Transplant Rejection
por: Nakano, Ryosuke, et al.
Publicado: (2021)

Complement-targeting therapeutics for ischemia-reperfusion injury in transplantation and the potential for ex vivo delivery
por: Delaura, Isabel F., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_nl8fs64hnriosro7isi24muklb